EAST GREENWICH, R.I., Oct. 23, 2017 -- As part of a webinar series sponsored by Compass IT Compliance, Tom Basiliere, CIO for Provant and its parent company Hooper Holmes (OTCQX:HPHW), is presenting a session on information security and mitigating breach risks on October 25, 2017. Provant is a national health and wellness leader that works with organizations across all industries to improve employee well-being.
|
|||
In his presentation, Basiliere will discuss traditional mitigation practices, layers of vulnerability, data architecture, the new risk landscape, and enhancing mitigation techniques.
With his deep experience in information technology (IT) and protection of wide-ranging, confidential data, Basiliere fully understands the need to integrate security into the strategic development process. As Chief Information Officer for Provant and Hooper Holmes, Basiliere has built an IT team that includes experienced senior-level data security professionals. The team conducts security architecture assessments as part of the software development cycle, effectively building safeguards into the systems from the outset.
If your organization is considering a corporate well-being program that involves confidential personal information, contact Provant at [email protected] for more information on how to engage employees and secure their data.
About Provant
Provant, a wholly-owned subsidiary of Hooper Holmes, Inc. is a leader in comprehensive workplace well-being solutions with a growing, global presence. Provant partners with employers and brokers to improve member health and productivity and support healthcare cost management. Provant touches millions of lives by delivering customized well-being strategies and services on-site, telephonically and digitally, utilizing advanced data management technology. www.ProvantHealth.com
For further information:
Provant
Elaine Peterson
Senior Director, Marketing & Communications
(401) 234-0165


Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Trump Blocks HieFo’s Emcore Chip Assets Deal Over National Security Concerns
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 



